The Black Man's Cardiovascular Inheritance. What the Data Say and What the Data Miss.

I was born in Nairobi. I trained in medicine in Kenya for eight years before completing my residency and cardiology fellowship in the United States. I sit at a specific intersection: a cardiologist of African descent practicing in a country where the cardiovascular data for men who look like me are among the most troubling in the developed world. I am going to address these data directly, with the specificity they deserve, because the man who reads this and adjusts his next decision is the reason this article exists.

The Mechanism

To understand why Black men carry this particular cardiovascular burden, you have to start inside the cell, not at the policy level.

Salt-sensitive hypertension and the RAAS. Blood pressure regulation runs largely through the renin-angiotensin-aldosterone system, or RAAS. The sequence is straightforward: when blood pressure drops or sodium falls, the kidney releases renin, which cleaves angiotensinogen to angiotensin I, which is converted by ACE to angiotensin II, the primary vasoconstrictor. Angiotensin II then triggers aldosterone release from the adrenal cortex. Aldosterone binds to receptors in the distal tubule of the kidney and drives sodium reabsorption, which draws water with it, raising circulating volume and restoring blood pressure. That is the system working as designed.

The problem in salt-sensitive hypertension is that the RAAS operates at the wrong set point. Salt-sensitive individuals retain sodium more aggressively at baseline, meaning a high-sodium diet drives blood pressure up through a volume-mediated mechanism rather than a renin-driven one. 5 / Solid Research published in Hypertension by Luft, Weinberger, and colleagues has characterized this for decades: Black Americans show higher rates of salt sensitivity, meaning blood pressure rises substantially with sodium loading and falls with sodium restriction, compared to white Americans. Some estimates place salt sensitivity prevalence at 73% in Black patients with hypertension versus approximately 36% in white hypertensive patients. The evolutionary explanation, proposed by Grim and Wilson in the 1990s, is that populations whose ancestors survived the trans-Atlantic crossing, during which salt and water depletion was severe, may have had selection pressure toward more efficient sodium retention. Whether that specific mechanism is the full explanation remains debated, but the physiological phenotype is not: Black Americans with hypertension trend toward lower plasma renin, higher aldosterone activity, and a volume-mediated pattern. 4 / Promising

The downstream consequences are not subtle. This volume-mediated phenotype means hypertension arrives earlier, progresses faster, and produces more severe target organ damage at the same blood pressure levels. The kidneys, heart, and brain bear the consequence: hypertensive nephrosclerosis, left ventricular hypertrophy, and hemorrhagic stroke occur at higher rates in Black men than in white men with nominally similar blood pressure readings at equivalent ages.

Aldosterone and cardiac remodeling. Aldosterone does more than retain sodium. In high or sustained concentrations, it drives direct myocardial fibrosis, stiffening the left ventricle over time. This contributes to the disproportionate rate of heart failure with preserved ejection fraction seen in Black patients, where the heart muscle is stiff rather than weak, and the clinical presentation often comes without the warning signs cardiologists are trained to look for in systolic failure.

The HPA axis under chronic load. The hypothalamic-pituitary-adrenal axis is the upstream governor of cortisol release, but it does not operate independently of the rest of the stress-response architecture. Chronic psychosocial stress, the sustained, low-intensity, unresolvable kind, produces a dysregulation pattern in the HPA axis: cortisol loses its normal diurnal rhythm. The morning cortisol surge, which should be high to mobilize energy for the day, blunts. Afternoon and evening cortisol, which should fall to allow restorative sleep, stays elevated. The system that was designed to respond to acute threat and then reset is now running at a low, continuous activation.

What does that produce, physiologically? Elevated sympathetic tone, because the autonomic nervous system tracks the HPA axis in a correlated pattern. Higher resting heart rate. Endothelial dysfunction, driven by reduced nitric oxide bioavailability as cortisol and catecholamines compete with the vasodilatory signals. Visceral fat deposition, because cortisol directs adipogenesis specifically to the intraabdominal compartment where adipocytes are metabolically active and drive insulin resistance. And a proinflammatory cytokine state, interleukin-6, interleukin-1-beta, and C-reactive protein elevated above the resting baseline, attacking the vascular endothelium from inside the bloodstream. 4 / Promising

Allostatic load and biological age. Allostatic load is the cumulative physiological cost of sustained adaptation to chronic stressors. It is measured not by any single biomarker but by the composite pattern across systems: blood pressure, cortisol patterns, inflammatory markers, metabolic indices, and telomere length. The man with high allostatic load is the man whose biological machinery has been running in a sustained stress state long enough that it has begun to wear. He may be 42 by the calendar. His vasculature may be tracking closer to 54.

What the Evidence Shows

The mortality numbers. A 2025 analysis in the American Journal of Preventive Cardiology examined cardiometabolic mortality before age 45 using National Vital Statistics System data. For a 25-year-old Black man, the calculated cumulative risk of cardiometabolic death before age 45 was one in 63. 5 / Solid (Rivera-Hernandez et al., Am J Prev Cardiol, 2025) For white men of the same starting age, the comparable figure is approximately one in 142. The disparity ratio is approximately 2.3 to 1. This is not a trend. This is a measured risk operating right now in the current generation.

The JACC 2024 analysis by Arun, Sawano, Caraballo, Yancy, Krumholz and colleagues quantified 779,387 excess cardiovascular deaths among Black Americans between 2000 and 2022, deaths beyond what would have been expected if Black Americans had the same age-adjusted cardiovascular mortality rate as white Americans. 5 / Solid (Arun et al., JACC, 2024) Of those, approximately 416,500 were Black men, representing more than 12.5 million excess years of potential life lost. That is more than 37,000 preventable cardiac deaths among Black men per year, sustained across two decades.

Earlier onset and worse initial presentation. In the CARDIA study, the Coronary Artery Risk Development in Young Adults longitudinal cohort, 26 of 27 incident heart failure cases in participants under 50 years of age were among Black participants. That is not statistical noise. That is a distribution so skewed it describes a fundamentally different disease timeline. Black men have approximately twice the incidence of sudden cardiac death compared to white men, with an annual SCD rate of roughly 0.18% per year in Black men versus 0.07% in white men. (AHA Scientific Statement, Circulation, 2016) Black SCD patients are more than six years younger on average than white SCD patients. When SCD is the first clinical presentation, the window for intervention has already closed.

The pharmacogenomic evidence. The ALLHAT trial, the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, remains the largest antihypertensive outcomes trial conducted in the United States, with 42,418 participants and a pre-specified analysis by race. 5 / Solid (ALLHAT Officers and Coordinators, JAMA, 2002) Among Black participants, chlorthalidone, a thiazide-type diuretic, was superior to lisinopril, an ACE inhibitor, for reducing heart failure risk by 32% and stroke risk by 40%. The biological reason maps directly to the hypertension phenotype: a volume-mediated, low-renin pattern responds to the volume-reducing action of diuretics. It responds less to the RAAS blockade mechanism of ACE inhibitors and ARBs, because when renin is already low, blocking its downstream effects delivers diminishing returns. Calcium channel blockers like amlodipine performed comparably to chlorthalidone for most endpoints.

The V-HeFT trials, Veterans Administration Cooperative Vasodilator Heart Failure Trials, further demonstrated that the combination of hydralazine and isosorbide dinitrate produced a greater survival benefit in Black patients with heart failure compared to white patients in the same trial, leading to the development of BiDil as the first race-specific cardiovascular drug approved by the FDA. The effect size was meaningful: in the A-HeFT trial specifically examining Black patients with heart failure, hydralazine-nitrate combination therapy reduced all-cause mortality by 43% and heart failure hospitalizations by 33% compared to placebo in Black patients already on guideline-directed background therapy. (Taylor et al., NEJM, 2004) 5 / Solid

The clinical implication is direct: a Black man with hypertension who has been on an ACE inhibitor for two years without blood pressure control below 130/80 is not simply in a “monitor and adjust” situation. He is potentially in a situation where the choice of drug class is mechanistically working against his predominant hypertension phenotype.

The weathering research. In 1992, Dr. Arline Geronimus at the University of Michigan proposed the weathering hypothesis: that Black Americans experience accelerated biological aging as a cumulative consequence of sustained social and economic adversity and political marginalization. By 2006, she and colleagues had grounded this in biomarker data. A study in the American Journal of Public Health measured allostatic load, a composite index of cortisol patterns, inflammatory markers, blood pressure, and metabolic function, across Black and white adults at multiple ages. Black adults showed significantly higher allostatic load at younger ages than white peers at comparable socioeconomic levels. 4 / Promising (Geronimus et al., Am J Public Health, 2006) The weathering was not a poverty effect. It was present across the income and education spectrum.

Subsequent research extended this into genetic markers of biological aging. Telomere length, the protective caps on chromosomal DNA that shorten with cellular replication and oxidative stress, is a validated marker of biological age. Studies in the REGARDS cohort and others have found shorter telomere lengths in Black Americans compared to white Americans at equivalent chronological ages, with the degree of shortening correlating with measures of perceived racial discrimination and chronic stress exposure, not only with socioeconomic position. Epigenetic aging clocks, which estimate biological age from patterns of DNA methylation, similarly show accelerated aging in Black Americans that is not fully explained by conventional risk factors.

The mechanism that produces these changes runs through the same HPA axis and inflammatory pathway described above. Chronic discrimination exposure, measured by validated scales like the Everyday Discrimination Scale, is independently associated with elevated diurnal cortisol, elevated hs-CRP, higher nocturnal blood pressure, and accelerated coronary artery calcification on imaging. 4 / Promising (Williams and colleagues, multiple peer-reviewed publications summarized in Williams et al., Harvard, 2021) This is not a political statement. This is the physiology of a recognized chronic stressor.

The INTERHEART study and psychosocial risk. The INTERHEART study, a large case-control study spanning 52 countries examining risk factors for myocardial infarction, found that psychosocial risk factors, including stress at work, stress at home, financial stress, depression, and loss of control, accounted for an odds ratio of approximately 2.7 for myocardial infarction, comparable to the risk from smoking and hyperlipidemia. (Yusuf et al., Lancet, 2004) 5 / Solid The psychosocial risk factor burden in Black American men is not the same as the average in a 52-country study. It is compounded by the structural context that Geronimus and Williams have characterized.

Social isolation and the Black male data. General population data from Holt-Lunstad and colleagues, a meta-analysis of 148 studies and more than 308,000 participants, found that social isolation increases mortality risk by 26% and loneliness by 29%, comparable in effect size to smoking 15 cigarettes per day. (Holt-Lunstad et al., Perspect Psychol Sci, 2015) 5 / Solid For Black men specifically, the social isolation picture is layered. Survey data consistently show that Black men are less likely than white men to report having confidants outside the immediate family, and that the norms around emotional disclosure in Black male culture, which overlap substantially with general masculine norms around stoicism and self-sufficiency, can make the social support network thinner in the dimension that matters biologically. The relevant dimension is not frequency of social contact. It is the kind of contact in which the person can be known without performance. Acquaintance networks do not buffer cortisol. Trusted relationships do.

The access gap in clinical claims data. The Institute of Medicine’s 2003 report Unequal Treatment documented, across an extensive review of clinical data, that racial and ethnic minorities receive lower-quality healthcare even after controlling for insurance status, income, and clinical severity. (IOM, Unequal Treatment, 2003) This includes being less likely to receive appropriate cardiac medication and less likely to undergo coronary revascularization at comparable indications. A 2024 follow-up review concluded that twenty years later, the documented pattern of unequal treatment persists. (IOM follow-up, 2024)

More specifically, analyses of insurance claims data have found that Black patients are significantly less likely to receive statin therapy at equivalent measured 10-year cardiovascular risk scores as white patients. The gap persists after controlling for insurance type. Black patients are less likely to receive cardiology referrals at comparable symptom presentations and less likely to be offered advanced lipid testing including ApoB and Lp(a). According to the Association of Black Cardiologists, more than 16.8 million Black Americans live in counties with limited or no cardiology care, in what the organization terms cardiology deserts, and more than 2 million live in areas with no cardiologist at all. (Association of Black Cardiologists, cardiologydeserts.org) 5 / Solid

The aggregate picture: the man carrying the highest cardiovascular risk is the man most likely to encounter the clinical system late, with less aggressive preventive therapy when he does arrive, and with risk that standard tools may underestimate.

What to Do This Week

1. Measure your blood pressure at home for seven days. Use a validated upper-arm cuff, not a wrist device. Take two readings per session, morning and evening, before caffeine or activity in the morning. Average all the results. If the average exceeds 130 systolic or 80 diastolic, bring the written log to your physician. A single office reading is not sufficient to guide treatment decisions. Seven days of home readings are.

2. Request ApoB, Lp(a), and hs-CRP at your next blood draw. These three markers are not on the standard lipid panel, and the standard lipid panel can appear normal while significant atherogenic risk is present. A man with normal LDL can have a high ApoB burden from small dense particles or a high Lp(a), a largely genetic particle that is elevated in 25 to 35 percent of people of African descent and is not meaningfully modifiable by diet or exercise. Lp(a) is measured once. It does not change substantially over a lifetime. The cost through a physician order or direct-access lab is roughly 30 to 50 dollars.

3. Ask your physician specifically about drug class selection if you are on antihypertensive therapy without controlled blood pressure. If you are on an ACE inhibitor or ARB as the only antihypertensive and your blood pressure remains above 130/80, ask whether a calcium channel blocker or thiazide-type diuretic should be the foundation of your regimen instead. The ALLHAT data are not obscure. The question is direct and answerable in a single appointment.

4. Establish preventive cardiology engagement now, not at fifty. The standard recommendation to begin cardiovascular screening at 45 to 50 was calibrated on populations that were not primarily Black. Given the earlier-onset risk timeline in Black men, and the CARDIA data showing that heart failure before 50 was almost entirely concentrated in Black participants, the cardiologist appointment that gets scheduled at 40 or earlier, or 35 with any family history of premature cardiac events, is the appointment that catches the problem before the first presentation is the catastrophic one.

5. Tell your physician your family history, specifically and in full. If a first-degree male relative, father, brother, or son, had a myocardial infarction, stroke, or cardiac death before age 60, that history changes your risk calculation in ways that must be spoken to be applied. The standard intake form does not always ask with the specificity needed. Provide it unprompted: who, what event, and at what age.

The data on Black men’s cardiovascular health is not ambiguous about the urgency. What it misses, and what no clinical trial has fully captured, is the specific cost of carrying the kind of sustained performance load that many Black professional men carry without a mechanism to put it down. That cost has a physiology. The six interventions with the most evidence behind them are not exotic: blood pressure control with the right drug class, advanced lipid testing, earlier imaging, aggressive management of sleep and metabolic risk, and a clinical relationship established before the system is needed for a crisis. The window in which those interventions change the outcome is real. It is earlier than most men expect, and it is still open.

The Signal Check is fifteen questions mapping the male cardiovascular risk pattern, including the physiological domains most commonly missed in standard screenings. It produces a specific starting point for your next clinical conversation.